A Media Evidence Guide for International Healthtech SaaS Launches

What makes a healthtech SaaS launch credible to the media?

A credible healthtech launch gives a reporter facts they can check, not just claims they can quote. Healthtech means technology used in health and care. SaaS means software supplied as an online service. The launch file should show what that software does, who it serves and where the proof stops.

Start with the task the product helps a person carry out. Does it book a visit, route a note or help a clinician review a record? These are different uses and call for different questions. A useful file states the use before it makes a broad claim about better care.

A press release can announce the launch, but it cannot hold every source and method. Keep a clear evidence file behind it. Give reporters the study, test record or approved customer quote that supports each main claim. State whether the result came from the company, a client or an outside research team.

The product team and qualified advisers must assess the rules that apply in each market. The FDA guide to device software functions explains its risk-based approach and the different groups of software it considers. Some software functions are not medical devices. A launch label alone does not settle the product's status.

FL PR's work on global healthcare communication also stresses the role of local context and expert voices. A new market needs more than a translated press release. The team needs to know what its readers already understand and what they need to check.

What should the launch evidence file contain?

The file should link each main claim to its source, owner, review date and limits. Keep one shared record so the press team and product team use the same facts. A short file with clear links is often easier to use than a large folder of mixed drafts. Mark which parts may be quoted and which need consent.

• Product scope: Who uses it, what it does now, where it is offered and what it does not do.
• Test record: The measure, dates, sample, starting point, method and team that checked the result.
• Safety checks: The role of human review, the path for reporting errors and the owner of each fix.
• Data use: The kinds of data used, who can see them and the status of local review.
• Expert roles: Who reviewed the product, which part they assessed and any paid or other link to the company.
• Use examples: Approved client cases, exact quotes, source links and the terms of their use.

For example, a team might say its tool reduced the time spent on a task. The file should define when the clock started and stopped. It should also state how many records were tested and which records were left out. This is a sample method, not a claim about any real product.

Ask what else changed during the test. A larger team, a new shift pattern or a different patient group could affect the result. Do not assign the whole change to the software without support. A reporter can use a limited result well if the limits are clear.

Keep gaps in view too. If a health outcome has not been studied, say so. If only the vendor checked the data, label the work as an internal review. An honest gap is more useful than a broad promise that no one can test.

How should product and health claims be written?

Write claims in four groups: what the tool does, what changed in a workflow, what changed in health, and what is planned. These groups need different proof. A working feature can be shown in a demo. A claim about patient health needs suitable research and expert review.

Describe a current feature with a clear verb and user. A tool may route a message or flag a missing field. That does not by itself prove safer care or better health. Future plans should use words such as planned, being tested or in development.

The FTC Health Products Compliance Guidance calls for truthful claims backed by adequate evidence. It also addresses the meaning an audience may infer, not just the exact words on the page. Its scope includes press releases and media appearances used to promote a product. The team should review both the stated claim and the message it may imply.

Place the main limit close to the claim. Do not hide it in a separate file that few readers will open. If a result concerns one site or one small test, make that scope clear. Keep a vendor estimate separate from a result the client has checked.

Clinical, legal and product review should have named owners. A communications lead can make the wording clearer but should not invent a clinical conclusion. If reviewers disagree, hold the disputed claim until the issue is resolved. A launch date is not evidence.

How should the story change across markets?

Change the angle to suit the market while keeping the facts and limits the same. A health desk may ask how the tool fits daily care. A business desk may ask about its buyers and funding. A trade title may want a detailed test of one feature.

Write a short brief for each market. Name the reader, the question and the local reason to cover it now. If there are no local data, do not present a global figure as a local result. If the product is not yet offered there, state that plainly.

The Acıbadem global communication analysis provides a useful first-party view of matching health expertise with a media context. It is not proof that a software product works. Use such material to plan the story, while keeping product claims tied to their own sources.

Choose spokespeople by what they know. A founder may explain the business need; a product lead may explain how the tool works. A clinician should speak only to the part they have reviewed. Confirm who can answer in the required language and time zone.

Keep the business model clear as well. Selling software does not make a company a healthcare provider. Offering support does not prove that it gives clinical advice. Clear roles help reporters avoid a misleading label and help buyers know who is responsible for each task.

What workflow keeps the launch file current?

A useful workflow gives each check an owner and allows the team to stop an unsupported claim. The schedule below is a planning example, not a legal deadline or proof that four weeks is enough. Product and market reviews may take longer. Set the release date around those needs.

• Four weeks before: Define the product scope, markets, claim list and review owners.
• Three weeks before: Check sources, test methods, client consent and the status of safety and data reviews.
• Two weeks before: Test the local angles, press questions and any agreed embargo terms.
• One week before: Rehearse the demo and interviews, then agree who handles a difficult question.
• Launch day: Share the current file, approved visuals, expert details and a contact who can respond.
• After launch: Record errors, new questions and changes to the product or its claims.

If the product uses artificial intelligence (AI), explain where human review sits and what happens when it makes an error. The WHO guidance on AI ethics and governance for health places ethics and human rights at the centre of design and use. Its principles support a clear account of roles and oversight.

Test the backup plan before the press event. Use an approved recording if the live demo fails. Use clearly labelled sample data when real patient data are not needed. A blurred screen alone does not settle all consent and data questions.

Give the public file a version date. When a fact changes, check the release, slides, images and all local copies. If a published story contains an error, send the journalist the exact correction and its source. Keep a record of the request and the response.

How should the team judge the launch result?

Judge the launch by accurate coverage and useful business signals, with clear limits on what caused each result. Count whether the story used the right product description and source. Then track relevant enquiries or demos where you have a sound way to do so. A mention alone does not prove a sale or a gain in trust.

Keep earned coverage, paid content and press-release distribution separate. Earned coverage is an editorial choice by the outlet; paid content involves a commercial placement. A distributed release may appear on many sites without a fresh editorial decision at each one. Do not report those outcomes as the same form of proof.

FL PR's review of global healthcare work and scientific collaboration can help teams frame the role of experts and sources. The launch still needs its own evidence. A case from a different service or product cannot fill a gap in a new claim.

Use a customer example only with clear permission and a sound method. Record the exact wording approved, when approval expires and which product version it covers. If the name must stay private, explain the reason and give enough context to assess the result. Do not turn an internal example into an independent study.

The same source file can help search and AI systems understand the product. Clear dates, names, scope and direct links make claims easier to check. They do not guarantee rankings or citations. Their value starts with a record that people can trust and use.

Frequently Asked Questions

These answers cover common decisions about the launch file and its use with the media.